In 2022, a variety of domestic drug ANDAs will be approved by the FDA, opening the door to the US market
Time of Update: 2022-05-08
On April 13, Huahai Pharmaceutical announced that the abbreviated new drug application (ANDA) for apixaban tablets submitted by the company to the US FDA has been provisionally approved .
Reduce postprandial hyperglycemia
Time of Update: 2022-04-17
Recently, Zhejiang Medicine entered the administrative examination and approval stage with the miglitol orally disintegrating tablet, which was produced as a generic version of Class 3, and this product is temporarily blank in the domestic market .
Alz Res Therapy: Alzheimer's treatment, artificial intelligence helps "old medicine new use
Time of Update: 2022-02-20
Blood vesselIn this study, they propose a web-based artificial intelligence (AI) framework capable of integrating multi-omics data as well as human protein-protein interactome networks to accurately infer drug targets affected by variants identified by GWAS point to identify new treatments .
Flunarizine Hydrochloride Capsules, a wholly-owned subsidiary of Zhendong Pharmaceutical, passed the consistency evaluation of generic drugs
Time of Update: 2022-01-24
On the morning of January 14, Zhendong Pharmaceutical announced that its wholly-owned subsidiary Anxin Bio had received the "Approval Notice for Supplementary Drug Application" issued by the State Drug Administration, and that Flunarizine Hydrochloride Capsules had been approved as a generic drug.
JAMA Neurology: Does new anti-epileptic drugs increase the risk of suicide in patients
Time of Update: 2021-09-11
In 2008, the US Food and Drug Administration Bureau ( the FDA ) issued an alert, said the anti- epileptic drugs (ASMs) will increase the suicide rate, which is based on 199 randomized placebo-controlled clinical trial meta-analysis, including 11 kinds of ASMs: Card Mazepine, febramide, gabapentin, lamotrigine, levetiracetam, oxcarbazepine, pregabalin, tiagabine, topiramate, sodium valproate, and zonisamide .
Preparation and research progress of drug-loaded albumin nanoparticles
Time of Update: 2021-07-01
The use of albumin to prepare nanoparticles can not only better load drugs, improve drug properties, but also increase the accumulation of drugs in tumor sites, which is a better strategy .
Research progress of albumin as a carrier of anti-tumor drug delivery system[J].
Roche's $425 million acquisition of geneWeave, an antibiotic diagnostics company
Time of Update: 2021-02-13
The two sides agreed that Roche would pay $190 million in advance to jointly develop a technology called "Fast Fire" that could be used to identify which antibiotics would be effective against terrain-positive, terrain-negative bacteria, help reduce mutations in bacterial resistance, and help patients make the right choices in the shortest possible time.
Due to process conditions, the potentially heavy drug Ao nitrogen flat compound was delayed by the FDA approval
Time of Update: 2021-01-19
On Tuesday, NASDAQ-listed Company Alkermes announced that it had received a letter from the U.S. Food and Drug Administration (FDA) on its new drug, APKS 3831 (Ao nitrogenpine/samidorphan), for adults with schizophrenia and bisomethic type I disorders.
20 price pneumococcal vaccine! Pfizer 20vPnC receives FDA Priority Review: For ≥ 18-year-olds
Time of Update: 2020-12-29
Dec 10, 2020 // -- Pfizer recently announced that the U.S. Food and Drug Administration (FDA) has accepted a 20-price pneumococcal polysaccharide binding vaccine (20vPnC) The Biological Products Licensing Application (BLA) for PF-06482077 will be reviewed as a priority for the vaccine for adults 18 years and older to prevent invasive diseases and pneumonia caused by streptococcus pneumoniae serotypes in the vaccine.
Manfu pharmaceutical hydrochloric acid pyrethride slow release tablets have been approved by the U.S. FDA
Time of Update: 2020-12-29
(hereinafter referred to as "Yichang People's Fu", the company holds 80% of its shares) received the APPROVAL number of the U.S. FDA on the release of hydrochloric acid pyrethone tablets, drug specifications of 1mg, 2mg, 3mg, 4mg.
The quality of the analytical methods in the analysis method development guide series is derived from the design
Time of Update: 2020-12-24
To ensure the safety, effective and quality control of drugs is the basic principle to be followed in drug research and development and evaluation, among which, quality control of drugs is the basis a
The method of executing experimental animals
Time of Update: 2020-11-03
During the operation, the experimenter grabbed the root of the sage with his right hand and lifted it, placed it on the cage cover or other rough surface, pressed the mouse's head and neck down with his left thumb and index finger, and forced the right hand to hold the root of the sage to pull back, resulting in dislocated cervical vertebrae, broken spinal cord and brain dry, and the experimental animal died immediately.
The FDA and EMA have accepted marketing applications for bimekizumab for the treatment of psoriasis
Time of Update: 2020-10-11
"After a series of positive Phase III data, we are pleased to announce that the FDA and EMA have accepted our application to use bimekizumab as a potential new treatment for psoriasis," said Emmanuel Caeymaex, executive vice president of UMB at UCB.
China's incremental review of cancer innovation drugs approved is based on five major focus points
Time of Update: 2020-09-30
CDE chemicals clinical director Yang Zhimin gave a speech report data show that in 2020 in the case of the epidemic, the number of new anti-tumor drug approval increased over the same period, from 15 to 19, while the proportion of domestic varieties increased from 26% to 47%.
Hengrui Pharmaceutical's innovative drug, the nec acid famini capsule, was approved clinically
Time of Update: 2020-09-27
. Recently, Hengrui Pharmaceuticals received a "Drug Clinical Trial Approval Notice" approved by the State Drug Administration, approving the company to carry out a randomized, open, controlled, multi-center Phase III clinical study of the innovative drug nephloric acid firminiry to treat advanced gastrointestinal mesothelioma, which failed to be treated by imatini.